|Mr. Karim Bitar||Chief Exec. Officer and Exec. Director||1.22M||N/A||52|
|Mr. Stephen Wilson||Group Fin. Director and Exec. Director||788k||N/A||57|
|Dr. Jonathan Lightner Ph.D.||Chief R&D and Scientific Officer||N/A||N/A||N/A|
|Mr. Dan Hartley||Group Gen. Counsel and Company Sec.||N/A||N/A||N/A|
|Ms. Angelle R. Rosata SPHR||Group HR Director||N/A||N/A||N/A|
Genus plc, together with its subsidiaries, engages in the application of quantitative genetics and biotechnology to animal breeding in the porcine, dairy, and beef sectors. It operates through four segments: Genus PIC, Genus ABS, Genus Asia, and Research and Development. The company sells breeding pigs under the PIC name; and bull semen to the dairy and beef markets under the ABS name. It offers boars and sows, as well as embryos. The company sells its products to farmers and food producers in North America, Latin America, Europe, the Middle East, Africa, and Asia. Genus plc was incorporated in 1994 and is headquartered in Basingstoke, the United Kingdom.
Genus plc’s ISS Governance QualityScore as of September 1, 2017 is 5. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 1; Compensation: 5.